4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040284
Options or other derivatives
- President & CEO acquired 128,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GOOD JENNIFER L · President & CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-29 | Grant or award : show line 1 in the form Performance Stock Options (right to buy) | +128,000 | 128,000 | D |
Loading xslF345X03/doc4.xml…